arrow
E

Eliane Sardh

Karolinska Institutet
H指数:19
被引数:2,151

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria Registry

急性间歇性卟啉病的临床特征与预后:欧洲卟啉病登记研究的启示

2026-04-170
PRE
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients

将全基因组测序整合到医疗环境中: 3219罕见病患者多个临床实体的高诊断率

2021-03-17161
OAAI
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
2020-06-11389
OAAI
Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2020-02-010
PREAI
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
2019-11-07112
OAAI
Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2019-10-011
PREAI
Management of acute hepatic porphyria attacks in europe and united states: EXPLORE international, prospective, natural history study
2019-04-010
PREAI
ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic porphyria patients
2019-04-016
PREAI
Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history study
2019-04-010
PREAI